| P2093 | author name string | Joseph E Cavanaugh | |
| | Susan K Schultz | |
| | Leigh J Beglinger | |
| | Natalie L Denburg | |
| | Torricia H Yamada | |
| | Christopher M Nguyen | |
| P2860 | cites work | “Mini-mental state” | Q25938989 |
| | A VISUAL RETENTION TEST FOR CLINICAL USE | Q29396941 |
| | Neuropsychological functioning and quality of life during the first year after completing chemotherapy for breast cancer | Q33816589 |
| | Cognitive function and reproductive hormones in adjuvant therapy for breast cancer: a critical review | Q34258430 |
| | Cognitive function after systemic therapy for breast cancer | Q34276123 |
| | Risk of subsequent dementia diagnoses does not vary by types of adjuvant chemotherapy in older women with breast cancer | Q34815323 |
| | A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer. | Q35551034 |
| | Neuropsychological effects of treatments for adults with cancer: a meta-analysis and review of the literature | Q35635738 |
| | The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: a meta-analysis of the current literature. | Q36173481 |
| | The potential for neuropsychology to inform functional outcomes research with breast cancer survivors | Q36487100 |
| | Neuropsychological outcomes of older breast cancer survivors: cognitive features ten or more years after chemotherapy | Q36809058 |
| | Cognitive impairments associated with breast cancer treatments: results from a longitudinal study | Q40070425 |
| | Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer | Q43011861 |
| | Late effects of adjuvant chemotherapy on cognitive function: a follow-up study in breast cancer patients | Q44114761 |
| | Cognitive impairment associated with adjuvant therapy in breast cancer | Q46647395 |
| | Cognitive function in breast cancer patients receiving adjuvant chemotherapy. | Q51079423 |
| | The cognitive effects of adjuvant chemotherapy in early stage breast cancer: a prospective study. | Q51975068 |
| | A meta-analysis of the neuropsychological effects of adjuvant chemotherapy treatment in women treated for breast cancer. | Q51985547 |
| | Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. | Q52015136 |
| | International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer. | Q53158179 |
| | A sharper Bonferroni procedure for multiple tests of significance | Q56622251 |
| | The association between neuropsychological impairment, self-perceived cognitive deficits, fatigue and health related quality of life in breast cancer survivors following standard adjuvant versus high-dose chemotherapy | Q79826254 |
| | Neuropsychological function in high-risk breast cancer survivors after stem-cell supported high-dose therapy versus standard-dose chemotherapy: evaluation of long-term treatment effects | Q81631400 |
| | Cognitive function of older patients receiving adjuvant chemotherapy for breast cancer: a pilot prospective longitudinal study | Q83999834 |
| P433 | issue | 4 | |
| P304 | page(s) | 862-868 | |
| P577 | publication date | 2012-05-14 | |
| P1433 | published in | Psycho-Oncology | Q2805644 |
| P1476 | title | Cognitive features 10 or more years after successful breast cancer survival: comparisons across types of cancer interventions | |
| P478 | volume | 22 | |